Camp4 Therapeutics (CAMP) Total Non-Current Liabilities (2023 - 2026)

Camp4 Therapeutics has reported Total Non-Current Liabilities for 4 years, with the latest figure at $74.5 million in Q1 2026.

• Quarterly Total Non-Current Liabilities rose 565.46% year-over-year to $74.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $74.5 million (up 565.46% YoY) and the FY2025 annual result came in at $70.1 million, up 364.35% from the prior year.
• Total Non-Current Liabilities improved to $74.5 million in Q1 2026 per CAMP's latest filing, from $70.1 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $74.5 million in Q1 2026 and troughed at $11.0 million in Q3 2025.
• A 4-year average of $28.5 million and a median of $15.8 million in 2023 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2025 and 2026: Total Non-Current Liabilities slumped 39.55% in 2025, then surged 565.46% in 2026.
• Over 4 years, Total Non-Current Liabilities stood at $16.5 million in 2023, then decreased by 8.69% to $15.1 million in 2024, then soared by 364.35% to $70.1 million in 2025, then rose by 6.35% to $74.5 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $74.5 million, $70.1 million, and $11.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.